CCL2 and breast cancer: Among these chemokines and cytokines potentially controlled by Wnt/β-catenin pathway, CCL2 has been reported as a target of the β-catenin/TCF/LEF pathway in breast cancer and plays a vital role in stimulating tumor progression and metastasis [54].